Whilst intermittent PTH treatment significantly boosts bone formation and reduces fracture risks28, chronic elevation of PTH in hyperparathyroidism nevertheless increases bone resorption and contributes to net bone loss over time21. This evidence concerns the gene PTH and hyperparathyroidism.